August 20, 2024 — Among patients undergoing lumbar spinal fusion, the presence of Modic changes is associated with differences in microbial diversity and metabolites in the lumbar cartilaginous ...
London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held, clinical stage pharmaceutical company developing an antibiotic formulation for intradiscal injection to treat Chronic Low ...
Persica is developing PP353, a potentially curative, opioid-sparing treatment for patients with chronic Low Back Pain Persica’s work builds on substantial evidence that chronic Low Back Pain with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback